Literature DB >> 9462670

Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?

P A Ganz.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9462670     DOI: 10.1093/jnci/90.3.182

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

Review 2.  Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

3.  Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.

Authors:  Patricia A Ganz; Lorna Kwan; Steven A Castellon; Amy Oppenheim; Julienne E Bower; Daniel H S Silverman; Steve W Cole; Michael R Irwin; Sonia Ancoli-Israel; Thomas R Belin
Journal:  J Natl Cancer Inst       Date:  2013-04-19       Impact factor: 13.506

Review 4.  Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment).

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2013-05-08       Impact factor: 2.512

Review 5.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Authors:  Andrew H Miller; Sonia Ancoli-Israel; Julienne E Bower; Lucile Capuron; Michael R Irwin
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.